Matt Biegler

Stock Analyst

(n/a)
# 4,641
Out of 4,647 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Oct 10, 2024
Initiates: Outperform
Price Target: $35
Current: $17.03
Upside: +105.52%